Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

S. K. Kumar, J. H. Lee, J. J. Lahuerta, G. Morgan, P. G. Richardson, J. Crowley, J. Haessler, J. Feather, A. Hoering, P. Moreau, X. Leleu, C. Hulin, S. K. Klein, P. Sonneveld, D. Siegel, J. Bladeé, H. Goldschmidt, S. Jagannath, J. S. Miguel, R. OrlowskiA. Palumbo, O. Sezer, S. V. Rajkumar

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)1153
Number of pages1
JournalLeukemia
Volume26
Issue number5
DOIs
StatePublished - May 2012

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this